BlackRock’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.8K | Sell |
76,855
-77,702
| -50% | -$24.1K | ﹤0.01% | 5048 |
|
|
2025
Q1 | $65K | Sell |
154,557
-1,482
| -0.9% | -$624 | ﹤0.01% | 4818 |
|
|
2024
Q4 | $109K | Buy |
156,039
+494
| +0.3% | +$346 | ﹤0.01% | 4714 |
|
|
2024
Q3 | $72.9K | Buy |
155,545
+2,964
| +2% | +$1.39K | ﹤0.01% | 4680 |
|
|
2024
Q2 | $253K | Buy |
152,581
+96,761
| +173% | +$161K | ﹤0.01% | 4451 |
|
|
2024
Q1 | $102K | Buy |
55,820
+211
| +0.4% | +$384 | ﹤0.01% | 4662 |
|
|
2023
Q4 | $103K | Sell |
55,609
-624
| -1% | -$1.15K | ﹤0.01% | 4719 |
|
|
2023
Q3 | $81K | Sell |
56,233
-2,184
| -4% | -$3.15K | ﹤0.01% | 4839 |
|
|
2023
Q2 | $107K | Buy |
58,417
+20,678
| +55% | +$37.8K | ﹤0.01% | 4806 |
|
|
2023
Q1 | $74.7K | Buy |
37,739
+1,122
| +3% | +$2.22K | ﹤0.01% | 4956 |
|
|
2022
Q4 | $76.9K | Buy |
36,617
+6,812
| +23% | +$14.3K | ﹤0.01% | 5034 |
|
|
2022
Q3 | $56K | Buy |
29,805
+2,296
| +8% | +$4.31K | ﹤0.01% | 5241 |
|
|
2022
Q2 | $58K | Buy |
27,509
+19,224
| +232% | +$40.5K | ﹤0.01% | 5288 |
|
|
2022
Q1 | $23K | Buy |
8,285
+288
| +4% | +$800 | ﹤0.01% | 5455 |
|
|
2021
Q4 | $51K | Buy |
+7,997
| New | +$51K | ﹤0.01% | 5322 |
|